Search Results 1711-1720 of 14810 for anti-TNF drugs

1. Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Immunosuppressive mediations (steroids, tumor necrosis factor (TNF)- ...

2. Fluorouracil (Intravenous Route, Injection Route) Description and Brand Names - Mayo Clinic

   Fluorouracil belongs to the group of medicines known as antimetabolites. It is used to treat cancer of the colon, rectum, breast, stomach, and pancreas. It may ...

3. Topotecan (Intravenous Route) Precautions - Mayo Clinic

   Male patients who have female partners should use effective birth control during treatment with this medicine and for at least 3 months after the last dose. If ...

4. Pillars and Programs - Center for Individualized Medicine - Mayo Clinic Research

   Additionally, this pillar investigates microorganisms with potential therapeutic benefits, validates strategies for gene therapy and analyzes biological age and ...

5. Antithyroid Agent (Oral Route, Rectal Route) Precautions - Mayo Clinic

   While you are being treated with antithyroid agents, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's ...

6. A Study to Evaluate Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Patients - Mayo Clinic

   About this study. The purpose of this study is to evaluate, jointly and independently among patients deemed at higher risk vs. lower risk for disability ...

7. Fulvestrant (Intramuscular Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

8. Science Saturday: Addressing the challenges of chimeric antigen receptor-T cell therapy - Mayo Clinic News Network

   For example, clinical trials have shown that a single infusion of CAR-T cell therapy targeted against a molecule known as BCMA that marks multiple myeloma cells ...

9. A Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps - Mayo Clinic

   - To evaluate functional dupilumab concentrations (systemic exposure) and incidence of treatment-emergent anti-drug antibodies. Participation eligibility.

10. Nilotinib (Oral Route) Description and Brand Names - Mayo Clinic

    Nilotinib belongs to the general group of medicines known as antineoplastics or cancer medicines. It interferes with the growth of cancer cells, ...